Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Trial
920
about 2.8 years
18+
6 sites in CT, IL, MA +3
What this study is about
This trial is testing whether a new perioperative anticoagulant management approach (PAUSE) is as safe as the current standard of care (ASRA) when used with DOACs in patients at high risk of bleeding who need surgery or invasive procedures. The goal is to show that PAUSE management will not increase the risk of major bleeding compared to ASRA management, while ensuring low DOAC levels before surgery.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.ASRA Perioperative DOAC Management
- 2.PAUSE Perioperative DOAC Management
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Cardiology / Heart